ACM
COLL icon

Aster Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

Aster Capital Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.85K Buy
+134
New +$4.58K ﹤0.01% 725
2025
Q1 		– Sell
-558
Closed -$16K – 1316
2024
Q4 		$16K Buy
+558
New +$18.5K 0.01% 674

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Aster Capital Management's COLL Position: Q2 2026 in Review

Aster Capital Management opened a new position in Collegium Pharmaceutical (COLL) in Q2 2026: 134 shares worth $4.85K. The stake represents ﹤0.01% of the portfolio and ranks #725 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in COLL as recently as Q4 2024.

Aster Capital Management first reported a position in COLL in Q4 2024 and has held it in 2 quarters since. The position peaked at $16K in Q4 2024. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Aster Capital Management held 134 shares of Collegium Pharmaceutical worth $4.85K as of Q2 2026.
  • Collegium Pharmaceutical was a new Aster Capital Management position in Q2 2026.
  • Collegium Pharmaceutical made up ﹤0.01% of Aster Capital Management's portfolio in Q2 2026, its #725 holding.
  • Aster Capital Management first reported a position in Collegium Pharmaceutical in Q4 2024 and has held it in 2 quarters since.
  • Aster Capital Management's Collegium Pharmaceutical position peaked at $16K in Q4 2024.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.